5

Respiratory and atopic outcomes in relation to traffic counts in the area of residence for children additionally exposed to environmental tobacco smoke

OutcomeCrude reference prevalence % (raw numbers)Exposure tertileCrude prevalence % (raw numbers)Adjusted OR (95% CI)
Asthma10.8 (126/1169)Low4.8 (4/83)0.438 (0.157–1.222)
Medium11.0 (11/100)1.009 (0.521–1.957)
High13.6 (14/103)1.343 (0.736–2.452)
Current asthma#5.2 (62/1193)Low1.2 (1/83)0.232 (0.032–1.700)
Medium5.9 (6/101)1.130 (0.472–2.706)
High9.7 (10/103)2.047 (1.005–4.171)§
Current wheeze#9.1 (107/1178)Low4.8 (4/83)0.523 (0.187–1.461)
Medium9.9 (10/101)1.095 (0.550–2.179)
High14.0 (14/100)1.697 (0.927–3.106)+
Cough19.1 (226/1186)Low20.7 (17/82)1.177 (0.674–2.054)
Medium25.7 (26/101)1.487 (0.927–2.385)+
High26.7 (27/101)1.543 (0.967–2.462)+
Hay fever10.4 (123/1179)Low6.1 (5/82)0.578 (0.227–1.472)
Medium16.8 (17/101)1.678 (0.944–2.981)+
High15.7 (16/102)1.739 (0.967–3.126)+
Skin­prick test ≥3 mm15.8 (110/695)Low13.7 (7/51)0.785 (0.339–1.817)
Medium23.8 (15/63)1.539 (0.812–2.918)
High28.8 (15/52)2.670 (1.353–5.268)ƒ
Pollen11.8 (82/694)Low11.5 (6/52)0.915 (0.372–2.247)
Medium19.4 (12/62)1.662 (0.829–3.331)
High25.0 (13/52)3.255 (1.581–6.699)ƒ
Specific IgE aeroallergens33.1 (164/496)Low25.7 (9/35)0.655 (0.296–1.451)
≥0.7 kU·mL−1Medium33.3 (16/48)1.003 (0.524–1.920)
High45.0 (18/40)1.761 (0.897–3.458)+
  • OR: odds ratio

  • CI: confidence interval

  • Ig: immunoglobulin

  • Low: 2600–15000 vehicles·day−1

  • Medium: 15001–30000 vehicles·day−1

  • High: >30000 vehicles·day−1 in street segment <50 m away from home

  • #: with respective symptoms during the last 12 months

  • : morning cough during the last 12 months. ORs adjusted for age, sex, socioeconomic status, and family history of asthma, hay fever, or eczema. Traffic categories analysed versus rest of population (reference)

  • +: p=0.05–≤0.10

  • §: p=0.01–≤0.05

  • ƒ: p≤0.01